Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M35.5Revenue $M1.1Net Margin (%)-1,247.6Altman Z-Score-15.2
Enterprise Value $M30.1EPS $-0.3Operating Margin %-1,339.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-1,247.3Higher ROA y-yY
Price/Book14.210-y EBITDA Growth Rate %--Quick Ratio1.9Cash flow > EarningsY
Price/Sales23.15-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-141.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-264.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M61.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NBY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NBY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NBY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pioneer Pharma (Singapore) Pte10% Owner 2015-03-03Buy2,590,000$0.6-3.33 view
SIECZKAREK MARK MDirector 2015-03-03Buy166,666$0.6-3.33 view
Najafi RaminChairman 2015-03-03Buy166,666$0.6-3.33 view
Najafi RaminChairman 2014-12-12Buy50,000$0.65-10.77 view
PAULSON THOMAS JCFO 2014-12-12Buy10,000$0.68-14.71 view
Stroman David W.SVP, Ophthalmic Product Devt. 2014-12-12Buy10,000$0.66-12.12 view
Najafi RaminChairman 2014-12-11Buy20,000$0.6-3.33 view
PAULSON THOMAS JCFO 2014-12-09Buy10,000$0.67-13.43 view
Najafi RaminChairman 2014-12-05Buy25,000$0.65-10.77 view
Wicks Tony D.S.Director 2014-12-02Sell20,000$0.7-17.14 view

Press Releases about NBY :

Quarterly/Annual Reports about NBY:

News about NBY:

Articles On GuruFocus.com
Novabay Pharmaceuticals' CEO Dr. Ramin Najafi Interviewed by The Life Sciences Report Jun 25 2015 
Own it Feb 29 2012 
NovaBay Pharmaceuticals Inc. (NBY) Chairman Ramin Najafi buys 1,000 Shares Aug 28 2009 
NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results Aug 14 2009 

More From Other Websites
NovaBay Pharmaceuticals to Hold Second Quarter 2015 Conference Call on August 13 Jul 30 2015
NovaBay Pharmaceuticals to Hold Second Quarter 2015 Conference Call on August 13 Jul 30 2015
NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jul 16 2015
NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE Jul 16 2015
NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE Jul 16 2015
China Pioneer Pharma Invited American Wound Care Expert to Provide Medical Advices for the Burn... Jul 10 2015
China Pioneer Pharma Offers Free NeutroPhase to Victims Suffered Burns in the Dust Explosion in... Jun 28 2015
Novabay Pharmaceuticals' CEO Dr. Ramin Najafi Interviewed by The Life Sciences Report Jun 25 2015
NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Jun 18 2015
Avenova Successfully Brings Relief to Patient with Challenging and Painful Eyelid Disease Jun 17 2015
NovaBay Pharmaceuticals Conference Call Today, June 9th, 2015, at 12:00 p.m. Eastern Time Jun 09 2015
NovaBay Pharmaceuticals Conference Call Today, June 9th, 2015, at 12:00 p.m. Eastern Time Jun 09 2015
Novabay Pharmaceuticals (NBY) Stock Spikes After FDA Approves Disinfection System Jun 04 2015
FDA Clears NovaBay Pharmaceuticals’ New High-Tech Device, intelli-Case, for Safely Disinfecting... Jun 04 2015
FDA Clears NovaBay Pharmaceuticals’ New High-Tech Device, intelli-Case, for Safely Disinfecting... Jun 04 2015
Panning for Golden Stocks Outside the Gold Industry May 28 2015
SeeThruEquity Initiates Coverage on NovaBay Pharmaceuticals with a Price Target of $1.87 May 27 2015
Doctors Embrace Avenova™ for Common Eye Conditions May 27 2015
NOVABAY PHARMACEUTICALS, INC. Financials May 22 2015
NovaBay Announces $6.86 Million “At Market” Private Placement May 22 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK